Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis

Published:2024-08 Issue: Volume:976 Page:176702
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Fernández-Bravo-Rodrigo Jaime^ORCID,Cavero-Redondo Iván^ORCID,Lucerón-Lucas-Torres Maribel^ORCID,Martínez-García Irene^ORCID,Flor-García Amparo,Barreda-Hernández Dolores,Pascual-Morena Carlos^ORCID

Funder

Universidad de Castilla-La Mancha

Spain Ministry of Science Innovation and Universities

Publisher

Elsevier BV

Reference91 articles.

1. Monoclonal antibodies as a preventive therapy for migraine: a meta-analysis;Alasad;Clin. Neurol. Neurosurg.,2020

2. Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE;Alsaadi;BMC Neurol.,2022

3. Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis;Andreou;J. Headache Pain,2022

4. Erenumab and OnabotulinumtoxinA combination therapy for the prevention of intractable chronic migraine without aura: a retrospective analysis;Armanious;J. Pain Palliat. Care Pharmacother.,2021

5. Assessment of study quality for systematic reviews: a comparison of the Cochrane collaboration risk of bias tool and the effective public health practice project quality assessment tool: methodological research;Armijo-Olivo;J. Eval. Clin. Pract.,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Modern Therapeutic Interventions for Migraine Management: A Systematic Review;Cureus;2024-08-21

2. Pharmacotherapy for osteoarthritis-related pain: current and emerging therapies;Expert Opinion on Pharmacotherapy;2024-06-12